Jiejuan Lai
Overview
Explore the profile of Jiejuan Lai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
91
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yu H, Zhang Y, Shuai L, Peng C, Zhao C, Jiang Y, et al.
Theranostics
. 2024 Oct;
14(17):6783-6797.
PMID: 39479458
Biliary complications after liver transplantation persistently affect patient prognosis and graft survival. Neutrophil-mediated immune injury is an important factor leading to biliary injury. However, the mechanism by which neutrophils reach...
2.
Jiang J, Zhang H, Lai J, Zhang S, Ou Y, Fu Y, et al.
J Hepatocell Carcinoma
. 2024 Aug;
11:1607-1622.
PMID: 39206422
Purpose: To compare the efficacy and safety of transarterial chemoembolization (TACE) plus lenvatinib and tislelizumab (TACE-Len-T) versus TACE plus lenvatinib (TACE-Len) as the first-line treatment for patients with unresectable hepatocellular...
3.
Zhao M, Wang J, Lai J, Liu F, Zhang Y, Cao L, et al.
World J Surg Oncol
. 2024 Aug;
22(1):225.
PMID: 39192321
Purpose: To summarize the abdominal computed tomography (CT) imaging and clinicopathological data of patients with SPNs of the pancreas and analyze the accuracy of preoperative CT diagnosis and features. Materials...
4.
Hu D, Lai J, Chen Q, Bai L
Stem Cell Res Ther
. 2024 Jul;
15(1):199.
PMID: 38971781
Background: Bone marrow-derived mesenchymal stem cell (MSC)-based therapy has become a major focus for treating liver fibrosis/cirrhosis. However, although these cell therapies promote the treatment of this disease, the heterogeneity...
5.
Pan S, Hu Y, Gan L, Lai J, Zheng P, Zhang Y, et al.
Ann Hepatol
. 2023 Dec;
29(2):101279.
PMID: 38123132
Introduction And Objectives: Cholangiocarcinoma (CCA) is characterized by early distant invasion and metastasis, whereas the underlying mechanism is still obscure. Increasing evidence shows that collagen type Ι alpha 1 (COL1A1)...
6.
Zhang H, Chen Q, Hu D, Lai J, Yan M, Wu Z, et al.
Exp Cell Res
. 2023 Dec;
434(1):113867.
PMID: 38043723
Long-term stem cell survival in the cirrhotic liver niche to maintain therapeutic efficacy has not been achieved. In a well-defined diethylnitrosamine (DEN)-induced liver fibrosis/cirrhosis animal model, we previously showed that...
7.
Tian Y, Lei Y, Wang Y, Lai J, Wang J, Xia F
Int J Oncol
. 2023 Sep;
63(5).
PMID: 37654171
Multidrug resistance (MDR) seriously limits the clinical application of chemotherapy. A mechanism underlying MDR is the overexpression of efflux transporters associated with chemotherapeutic drugs. P‑glycoprotein (P‑gp) is an ATP‑binding cassette...
8.
Chen Q, Yang Z, Lin H, Lai J, Hu D, Yan M, et al.
Front Immunol
. 2023 Aug;
14:1162439.
PMID: 37614233
Allostimulated CD8 T cells (aCD8 T cells), as the main mediators of acute liver rejection (ARJ), are hyposensitive to apoptosis due to the inactivation of death receptor FAS-mediated pathways and...
9.
Chen Q, Yan M, Lin H, Lai J, Yang Z, Hu D, et al.
Cell Death Discov
. 2023 Jan;
9(1):13.
PMID: 36658107
Intrahepatic stem/progenitor cells and cytotoxic CD8 T cells (CD8 T cells) in the cirrhotic liver undergo apoptosis, which potentially facilitates progression to cancer. Here, we report that hepatocyte growth factor...
10.
Zhang H, Wu Z, Hu D, Yan M, Sun J, Lai J, et al.
Vaccines (Basel)
. 2022 Jul;
10(7).
PMID: 35891187
Neuro-glia antigen 2/chondroitin sulfate proteoglycan 4 (NG2/CSPG4, also called MCSP, HMW-MAA, MSK16, MCSPG, MEL-CSPG, or gp240) is a large cell-surface antigen and an unusual cell membrane integral glycoprotein frequently expressed...